[Health Technology Assessment Report : Opdivo (ESCC - first-line treatment)
Center for Drug Evaluation
Record ID 32018013828
Chinese (Mandarin)
Details
Project Status:
Completed
Year Published:
2024
URL for published report:
https://www.cde.org.tw/media/rrkf4rkp/11302_4_%E8%A8%8E%E8%AB%96%E6%A1%88%E7%AC%AC3%E6%A1%88_opdivo-escc%E4%B8%80%E7%B7%9A.pdf?mediaDL=true
English language abstract:
There is no English language summary available
Publication Type:
Not Assigned
MeSH Terms
- Esophageal Neoplasms
- Esophageal Squamous Cell Carcinoma
- Nivolumab
- Antibodies, Monoclonal, Humanized
Contact
Organisation Name:
Center for Drug Evaluation
Contact Address:
3F.,No.465, Sec.6, Zhongxiao E. Rd., Taipei 11557, Taiwan. R.O.C.
Contact Name:
Li Ying (Grace) Huang
Contact Email:
lyhuang277@cde.org.tw
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.